Localized insulin-derived amyloidosis in patients with diabetes mellitus: a case report

Human Pathology

Volumn 40, Issue 11, 2009, Pages 1655-1660

  Yumlu, Saniye ^a   Barany, Robert ^b   Eriksson, Magdalena ^a   Röcken, Christoph ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b St Antonius Hospital   (Germany)

Author keywords

Amyloidosis; Diabetes mellitus; Insulin

Indexed keywords

ACTRAPAN; COMBINSULIN CR; CONGO RED; HUMANINSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; NEUTRAL INSULIN; RECOMBINANT HUMAN INSULIN; UNCLASSIFIED DRUG; VELSULIN;

ABDOMINAL RADIOGRAPHY; ADULT; AGED; AMYLOIDOSIS; ARTICLE; BONE MARROW BIOPSY; CANCER DIAGNOSIS; CANCER SIZE; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INJECTION SITE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RECTUM BIOPSY; SKIN TUMOR; THORAX RADIOGRAPHY;

ADULT; AGED; AMYLOIDOSIS; DIABETES MELLITUS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOHISTOCHEMISTRY; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; SKIN NEOPLASMS;

EID: 67549142772     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.02.019     Document Type: Article

References (17)

1. Merlini G., and Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med 349 (2003) 583-596
2. Westermark P., Benson M.D., Buxbaum J.N., et al. A primer of amyloid nomenclature. Amyloid 14 (2007) 179-183
3. Westermark P., Benson M.D., Buxbaum J.N., et al. Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid 12 (2005) 1-4
4. Kebbel A., and Röcken C. Immunohistochemical classification of amyloid in surgical pathology revisited. Am J Surg Pathol 30 (2006) 673-683
5. Haataja L., Gurlo T., Huang C.J., and Butler P.C. Islet Amyloid in type 2 diabetes, and the toxic oligomer hypothesis. Endocr Rev 29 (2008) 303-316
6. Swift B. Examination of insulin injection sites: an unexpected finding of localized amyloidosis. Diabet Med 19 (2002) 881-882
7. Gregorini G., Izzi C., Obici L., et al. Renal apolipoprotein A-I amyloidosis: a rare and usually ignored cause of hereditary tubulointerstitial nephritis. J Am Soc Nephrol 16 (2005) 3680-3686
8. Bohne S., Sletten K., Menard R., et al. Cleavage of AL amyloid proteins and AL amyloid deposits by cathepsins B, K, and L. J Pathol 203 (2004) 528-537
9. Dische F.E., Wernstedt C., Westermark G.T., et al. Insulin as an amyloid-fibril protein at sites of repeated insulin injections in a diabetic patient. Diabetologia 31 (1988) 158-161
10. Sahoo S., Reeves W., and DeMay R.M. Amyloid tumor: a clinical and cytomorphologic study. Diagn Cytopathol 28 (2003) 325-328
11. Albert S.G., Obadiah J., Parseghian S.A., Yadira H.M., and Mooradian A.D. Severe insulin resistance associated with subcutaneous amyloid deposition. Diabetes Res Clin Pract 75 (2007) 374-376
12. Störkel S., Schneider H.M., Müntefering H., and Kashiwagi S. Iatrogenic, insulin-dependent, local amyloidosis. Lab Invest 48 (1983) 108-111
13. Dember L.M., and Jaber B.L. Dialysis-related amyloidosis: late finding or hidden epidemic?. Semin Dial 19 (2006) 105-109
14. Yamamoto S., and Kazama J.J. Mechanism of beta(2)-microglobulin-related amyloid fibril formation in CKD. Clin Calcium 17 (2007) 740-744
15. Wogulis M., Wright S., Cunningham D., Chilcote T., Powell K., and Rydel R.E. Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death. J Neurosci 25 (2005) 1071-1080
16. Vardar B., and Kizilci S. Incidence of lipohypertrophy in diabetic patients and a study of influencing factors. Diabetes Res Clin Pract 77 (2007) 231-236
17. Kordonouri O., Lauterborn R., and Deiss D. Lipohypertrophy in young patients with type 1 diabetes. Diabetes Care 25 (2002) 634